News PCL, Inc.

Equities

A241820

KR7241820000

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
1,171 ^KRW	-0.26%		-2.34%	-67.34%

Jan. 16	PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets	CI
2023	PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets	Jan. 15	CI
PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets	Dec. 25	CI
PCL, Inc. announced that it expects to receive KRW 9.99999885 billion in funding from Global Emerging Markets	Dec. 20	CI
PCL, Inc. announced that it expects to receive KRW 9.99999838 billion in funding from Global Emerging Markets	Dec. 14	CI
South Korean Stocks Close Lower as Uncertainties Around US Debt Ceiling Deal Remain; PCL Loses 13%	23-05-31	MT
PCL to Raise 36 Billion Won via Share Issuance	23-05-31	MT
PCL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
PCL, Inc. announced that it has received KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.	22-12-28	CI
PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4%	22-12-21	MT
PCL, Inc. announced that it expects to receive KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.	22-12-20	CI
PCL, Inc. terminated the acquisition of 40.76% stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd.	22-12-11	CI
PCL, Inc. announced that it has received KRW 12.060247575 billion in funding	22-12-11	CI
OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.	22-11-10	CI
PCL, Inc. agreed to acquire unknown minority stake in stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion.	22-11-10	CI
PCL, Inc.(KOSDAQ:A241820) dropped from S&P Global BMI Index	22-04-07	CI
PCL, Inc.(KOSDAQ:A241820) added to S&P Global BMI Index	21-09-20	CI
MCureX Therapeutics, Inc. announced that it expects to receive KRW 2 billion in funding from OliX Pharmaceuticals,Inc, PCL, Inc., Samyang Holdings Corporation	21-06-22	CI
PCL, Inc. announced that it has received KRW 40.499938368 billion in funding from a group of investors	21-03-24	CI
Datametrex AI Limited Secures Authorization by Health Canada for PCL Inc.'s COVID19 Rapid Antigen Test Kit	21-03-23	CI
PCL, Inc. announced that it expects to receive KRW 40.499938368 billion in funding from a group of investors	21-03-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PCL, Inc.

Equities

A241820

KR7241820000

Summary

Filters